Clinical Trial Update: A Preliminary Study of Sustained-Release Bupropion for Smoking Cessation in Bipolar Affective Disorder [Phase 1, Phase 2]

View source ↗

Summary

This report summarizes a completed Phase 1/2 trial evaluating sustained-release bupropion for smoking cessation. The study enrolled individuals with bipolar dis…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bipolar Disorder

Drugs mentioned

• Bupropion sustained-release (bupropion)

Snippet

Sponsor: National Institute on Drug Abuse (NIDA) | Conditions: Bipolar Disorder | Phase 1, Phase 2 | Status: COMPLETED